Stay updated with breaking news from Oriella limited. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
KAHR Announces $46.5 Million Financing to Advance its Multifunctional Immunotherapeutic Pipeline prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Israeli cancer drug developer KAHR raises $46.5m globes.co.il - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globes.co.il Daily Mail and Mail on Sunday newspapers.
Immunotherapy startup KAHR gets $46.5 million from investors timesofisrael.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from timesofisrael.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Samsung Biologics (KRX: 207940.KS), the world s leading contract development and manufacturing organization, signed a strategic partnership. ....
/PRNewswire/ KAHR, a clinical-stage cancer immunotherapy company developing novel bi-functional fusion proteins, and Cancer Focus Fund, LP, a unique venture. ....